Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ket10
- Development stage
- Unknown
- Administration
- Intravenous, Intramuscular, Intranasal, Subcutaneous, Oral, Sublingual, Rectal, Transdermal, Epidural, Intrathecal, Inhalation
01
Overview
Ket10 is a code name used in scientific studies to refer to a 10 mg/kg dose of a drug. In the provided context, this code has been applied to ketoconazole, an antifungal agent with prophylactic antimalarial activity, and ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist known for its antidepressant, antinociceptive, and anti-inflammatory effects. Given its application to different active pharmaceutical ingredients, 'Ket10' serves as a non-specific identifier for a dosage rather than a unique drug entity.
Beyond the preview
Go deeper on Ket10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ket10.